-
Smith became Viatris' CEO,
succeeding Michael Goettler.
Smith previously served on the company's
board since 2022. In
April 2023,
Viatris was recognized...
-
Creation VIATRIS TSR
Execution Plan" (PDF).
Champion For
Global Health.
Retrieved October 22, 2020. Sabatini,
Patricia (November 12, 2019). "
Viatris picked...
-
Biocon signed a
collaboration agreement with
Viatris to
develop and
commercialize generic biologics.
Viatris and
Biocon will
share development, capital...
- acid In some countries,
Dymista is
marketed by
Viatris after Upjohn merged with
Mylan to
create Viatris. "Breakthrough:
Nasal Spray May Soon
Replace Pills...
- In some countries,
Perforomist is
marketed by
Viatris after Upjohn merged with
Mylan to
create Viatris.
Arformoterol ((R,R)-(−)-formoterol) — an enantiopure...
- The
merger was
completed in
November 2020, and the new
company was
named Viatris. W. E.
Upjohn Institute for
Employment Research Lohrstorfer, Martha; Larson...
-
Tolterodine by
Sabaa and
Incont L.A. by Adwia. In the US,
Detrol is
marketed by
Viatris after Upjohn was spun off from Pfizer. "Detrusitol 1mg film-coated tablets...
- Zenpep. In some countries,
Creon is
marketed by
Viatris after Upjohn merged with
Mylan to
create Viatris.
Longstanding pancreatic enzyme replacement products...
-
chemically related to low
molecular weight heparins. It is
marketed by
Viatris. A
generic version developed by
Alchemia is
marketed within the US by Dr...
-
Covidien Univar –
Univar Ltd
Valeant –
Valeant Pharmaceuticals Ltd
Viatris –
Viatris Pharmaceuticals Ltd W-L –
Warner Lambert UK Ltd (Pfizer Ltd) Warner...
